Effect of CVP and IOH on AKI and AKD
Venous Congestion Rather Than Intraoperative Hypotension is Associated With Acute Adverse Kidney Events After Cardiac Surgery
1 other identifier
observational
5,127
1 country
1
Brief Summary
This study was aimed to explore the effect of intraoperative venous congestion and intraoperative hypotension (IOH) on acute adverse kidney events, defined as acute kidney injury (AKI) and acute kidney disease (AKD), after cardiac surgery
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2016
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2021
CompletedFirst Submitted
Initial submission to the registry
December 26, 2021
CompletedFirst Posted
Study publicly available on registry
February 3, 2022
CompletedFebruary 3, 2022
January 1, 2022
5.1 years
December 26, 2021
January 23, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
CSA-AKI
Cardiovascular surgery associated acute kidney injury. AKI was defined using the Kidney Disease: Improving Global Outcome (KDIGO) Clinical Practice Guideline for Acute Kidney Injury as an absolute increase in serum creatinine of ≥ 26 μmol/L within 48 hours or an increase in serum creatinine beyond 1.5 times the baseline value within 7 days
7 days post operation
AKD
Acute Kidney Disease, which was defined according to the criteria recommended by the Acute Disease Quality Initiative (ADQI) workgroup.4 AKI was quantified within the 7 days' postoperative period, while AKD was defined as serum creatinine value elevated to 1.5 times the baseline value between 8- and 90-day post-operation period.
8 to 90 days post operation
Secondary Outcomes (6)
Incidence of AKD of stage 2 and above
8 to 90 days post operation
RRT initiation
from the end of operation to the discharge from hospital, up to 90 days.
value of eGFR
7 days after operation
inpatient mortality
30 days after inhospital
ICU length of stay
from the end of operation to the discharge from ICU, up to 90 days.
- +1 more secondary outcomes
Study Arms (6)
CVP ≥ 12
central venous pressure ≥12 mmHg
CVP ≥ 16
central venous pressure ≥16 mmHg
CVP ≥ 20
central venous pressure ≥20 mmHg
MAP ≤ 55 mmHg
mean arterial pressure ≤55 mmHg
MAP ≤ 65 mmHg
mean arterial pressure ≤65 mmHg
MAP ≤ 75 mmHg
mean arterial pressure ≤75 mmHg
Interventions
Venous congestion exposures were quantified as area under the curve (AUC) of central venous pressure ≥12, 16 or 20 mmHg
Introperation hypotension exposures were quantified as area under the curve (AUC) of mean arterial pressure ≤55, 65, 75 mmHg
Eligibility Criteria
All adults undergoing cardiac surgery between 2016 and 2020 (data analysed in 2021) using electronic health records collected from the Nanjing First Hospital.
You may qualify if:
- Patients aged 18 years and older,
- Patients underwent cardiac surgery (coronary artery bypass grafting, heart valve surgery, heart transplant or surgical excision of intracardiac myxoma)
- Patients receiving invasive intraoperative BP monitoring during surgery
- Patients underwent cardiopulmonary bypass (CPB) during surgery
You may not qualify if:
- Pre-existing renal insufficiency defined by presence of abnormal preoperative serum creatinine ≥ 133 μmol/L and/or preoperative diagnosis of renal insufficiency within 6 months'preoperative period.
- Patients with preoperative dialysis dependence within 60 days before the index surgical procedure,
- Surgical duration less than 30 minutes
- Surgery on the aorta
- Insufficient hemodynamic and laboratory data for outcomes and/or exposure ascertainment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Nanjing First Hospital
Nanjing, Jiangsu, 210006, China
Related Publications (10)
Vervoort D, Swain JD, Pezzella AT, Kpodonu J. Cardiac Surgery in Low- and Middle-Income Countries: A State-of-the-Art Review. Ann Thorac Surg. 2021 Apr;111(4):1394-1400. doi: 10.1016/j.athoracsur.2020.05.181. Epub 2020 Aug 6.
PMID: 32771467BACKGROUNDWeisse AB. Cardiac surgery: a century of progress. Tex Heart Inst J. 2011;38(5):486-90.
PMID: 22163121BACKGROUNDWang Y, Bellomo R. Cardiac surgery-associated acute kidney injury: risk factors, pathophysiology and treatment. Nat Rev Nephrol. 2017 Nov;13(11):697-711. doi: 10.1038/nrneph.2017.119. Epub 2017 Sep 4.
PMID: 28869251BACKGROUNDOrtega-Loubon C, Fernandez-Molina M, Carrascal-Hinojal Y, Fulquet-Carreras E. Cardiac surgery-associated acute kidney injury. Ann Card Anaesth. 2016 Oct-Dec;19(4):687-698. doi: 10.4103/0971-9784.191578.
PMID: 27716701BACKGROUNDSwaminathan M, Hudson CC, Phillips-Bute BG, Patel UD, Mathew JP, Newman MF, Milano CA, Shaw AD, Stafford-Smith M. Impact of early renal recovery on survival after cardiac surgery-associated acute kidney injury. Ann Thorac Surg. 2010 Apr;89(4):1098-104. doi: 10.1016/j.athoracsur.2009.12.018.
PMID: 20338313BACKGROUNDRobert AM, Kramer RS, Dacey LJ, Charlesworth DC, Leavitt BJ, Helm RE, Hernandez F, Sardella GL, Frumiento C, Likosky DS, Brown JR; Northern New England Cardiovascular Disease Study Group. Cardiac surgery-associated acute kidney injury: a comparison of two consensus criteria. Ann Thorac Surg. 2010 Dec;90(6):1939-43. doi: 10.1016/j.athoracsur.2010.08.018.
PMID: 21095340BACKGROUNDEnglberger L, Suri RM, Li Z, Casey ET, Daly RC, Dearani JA, Schaff HV. Clinical accuracy of RIFLE and Acute Kidney Injury Network (AKIN) criteria for acute kidney injury in patients undergoing cardiac surgery. Crit Care. 2011;15(1):R16. doi: 10.1186/cc9960. Epub 2011 Jan 13.
PMID: 21232094BACKGROUNDArora P, Rajagopalam S, Ranjan R, Kolli H, Singh M, Venuto R, Lohr J. Preoperative use of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers is associated with increased risk for acute kidney injury after cardiovascular surgery. Clin J Am Soc Nephrol. 2008 Sep;3(5):1266-73. doi: 10.2215/CJN.05271107. Epub 2008 Jul 30.
PMID: 18667735BACKGROUNDOuzounian M, Buth KJ, Valeeva L, Morton CC, Hassan A, Ali IS. Impact of preoperative angiotensin-converting enzyme inhibitor use on clinical outcomes after cardiac surgery. Ann Thorac Surg. 2012 Feb;93(2):559-64. doi: 10.1016/j.athoracsur.2011.10.058.
PMID: 22269723BACKGROUNDWelten GM, Chonchol M, Schouten O, Hoeks S, Bax JJ, van Domburg RT, van Sambeek M, Poldermans D. Statin use is associated with early recovery of kidney injury after vascular surgery and improved long-term outcome. Nephrol Dial Transplant. 2008 Dec;23(12):3867-73. doi: 10.1093/ndt/gfn381. Epub 2008 Jul 15.
PMID: 18628367BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Lihai Chen, PhD
chenlihai1983@163.com
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Doctor
Study Record Dates
First Submitted
December 26, 2021
First Posted
February 3, 2022
Study Start
June 1, 2016
Primary Completion
June 30, 2021
Study Completion
August 1, 2021
Last Updated
February 3, 2022
Record last verified: 2022-01
Data Sharing
- IPD Sharing
- Will not share